The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Onychomycosis Drugs Market Research Report 2024
Synopsis
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
The global Onychomycosis Drugs market was valued at US$ 3290 million in 2023 and is anticipated to reach US$ 4179.7 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Onychomycosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Onychomycosis Drugs.
Report Scope
The Onychomycosis Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Onychomycosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Onychomycosis Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
GSK
Novartis
Pfizer
Bausch Health
Kaken Pharmaceutical
Galderma
Bayer
Lumenis
Moberg Pharma
Cipla
Biofrontera
Leo Pharma
Dr. Reddy's Laboratories
Medimetriks Pharmaceuticals
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical
Segment by Type
Oral Medicine
External Medicine
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Onychomycosis Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
The global Onychomycosis Drugs market was valued at US$ 3290 million in 2023 and is anticipated to reach US$ 4179.7 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Onychomycosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Onychomycosis Drugs.
Report Scope
The Onychomycosis Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Onychomycosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Onychomycosis Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
GSK
Novartis
Pfizer
Bausch Health
Kaken Pharmaceutical
Galderma
Bayer
Lumenis
Moberg Pharma
Cipla
Biofrontera
Leo Pharma
Dr. Reddy's Laboratories
Medimetriks Pharmaceuticals
Xiuzheng Pharmaceutical
Letai
Qilu Pharmaceutical
Segment by Type
Oral Medicine
External Medicine
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Onychomycosis Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onychomycosis Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Medicine
1.2.3 External Medicine
1.3 Market by Application
1.3.1 Global Onychomycosis Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Onychomycosis Drugs Market Perspective (2019-2030)
2.2 Onychomycosis Drugs Growth Trends by Region
2.2.1 Global Onychomycosis Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Onychomycosis Drugs Historic Market Size by Region (2019-2024)
2.2.3 Onychomycosis Drugs Forecasted Market Size by Region (2025-2030)
2.3 Onychomycosis Drugs Market Dynamics
2.3.1 Onychomycosis Drugs Industry Trends
2.3.2 Onychomycosis Drugs Market Drivers
2.3.3 Onychomycosis Drugs Market Challenges
2.3.4 Onychomycosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Onychomycosis Drugs Players by Revenue
3.1.1 Global Top Onychomycosis Drugs Players by Revenue (2019-2024)
3.1.2 Global Onychomycosis Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Onychomycosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Onychomycosis Drugs Revenue
3.4 Global Onychomycosis Drugs Market Concentration Ratio
3.4.1 Global Onychomycosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onychomycosis Drugs Revenue in 2023
3.5 Onychomycosis Drugs Key Players Head office and Area Served
3.6 Key Players Onychomycosis Drugs Product Solution and Service
3.7 Date of Enter into Onychomycosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Onychomycosis Drugs Breakdown Data by Type
4.1 Global Onychomycosis Drugs Historic Market Size by Type (2019-2024)
4.2 Global Onychomycosis Drugs Forecasted Market Size by Type (2025-2030)
5 Onychomycosis Drugs Breakdown Data by Application
5.1 Global Onychomycosis Drugs Historic Market Size by Application (2019-2024)
5.2 Global Onychomycosis Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Onychomycosis Drugs Market Size (2019-2030)
6.2 North America Onychomycosis Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Onychomycosis Drugs Market Size by Country (2019-2024)
6.4 North America Onychomycosis Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Onychomycosis Drugs Market Size (2019-2030)
7.2 Europe Onychomycosis Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Onychomycosis Drugs Market Size by Country (2019-2024)
7.4 Europe Onychomycosis Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis Drugs Market Size (2019-2030)
8.2 Asia-Pacific Onychomycosis Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Onychomycosis Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Onychomycosis Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Onychomycosis Drugs Market Size (2019-2030)
9.2 Latin America Onychomycosis Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Onychomycosis Drugs Market Size by Country (2019-2024)
9.4 Latin America Onychomycosis Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis Drugs Market Size (2019-2030)
10.2 Middle East & Africa Onychomycosis Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Onychomycosis Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Onychomycosis Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Onychomycosis Drugs Introduction
11.1.4 Johnson & Johnson Revenue in Onychomycosis Drugs Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Onychomycosis Drugs Introduction
11.2.4 GSK Revenue in Onychomycosis Drugs Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Onychomycosis Drugs Introduction
11.3.4 Novartis Revenue in Onychomycosis Drugs Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Onychomycosis Drugs Introduction
11.4.4 Pfizer Revenue in Onychomycosis Drugs Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Bausch Health
11.5.1 Bausch Health Company Detail
11.5.2 Bausch Health Business Overview
11.5.3 Bausch Health Onychomycosis Drugs Introduction
11.5.4 Bausch Health Revenue in Onychomycosis Drugs Business (2019-2024)
11.5.5 Bausch Health Recent Development
11.6 Kaken Pharmaceutical
11.6.1 Kaken Pharmaceutical Company Detail
11.6.2 Kaken Pharmaceutical Business Overview
11.6.3 Kaken Pharmaceutical Onychomycosis Drugs Introduction
11.6.4 Kaken Pharmaceutical Revenue in Onychomycosis Drugs Business (2019-2024)
11.6.5 Kaken Pharmaceutical Recent Development
11.7 Galderma
11.7.1 Galderma Company Detail
11.7.2 Galderma Business Overview
11.7.3 Galderma Onychomycosis Drugs Introduction
11.7.4 Galderma Revenue in Onychomycosis Drugs Business (2019-2024)
11.7.5 Galderma Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Onychomycosis Drugs Introduction
11.8.4 Bayer Revenue in Onychomycosis Drugs Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 Lumenis
11.9.1 Lumenis Company Detail
11.9.2 Lumenis Business Overview
11.9.3 Lumenis Onychomycosis Drugs Introduction
11.9.4 Lumenis Revenue in Onychomycosis Drugs Business (2019-2024)
11.9.5 Lumenis Recent Development
11.10 Moberg Pharma
11.10.1 Moberg Pharma Company Detail
11.10.2 Moberg Pharma Business Overview
11.10.3 Moberg Pharma Onychomycosis Drugs Introduction
11.10.4 Moberg Pharma Revenue in Onychomycosis Drugs Business (2019-2024)
11.10.5 Moberg Pharma Recent Development
11.11 Cipla
11.11.1 Cipla Company Detail
11.11.2 Cipla Business Overview
11.11.3 Cipla Onychomycosis Drugs Introduction
11.11.4 Cipla Revenue in Onychomycosis Drugs Business (2019-2024)
11.11.5 Cipla Recent Development
11.12 Biofrontera
11.12.1 Biofrontera Company Detail
11.12.2 Biofrontera Business Overview
11.12.3 Biofrontera Onychomycosis Drugs Introduction
11.12.4 Biofrontera Revenue in Onychomycosis Drugs Business (2019-2024)
11.12.5 Biofrontera Recent Development
11.13 Leo Pharma
11.13.1 Leo Pharma Company Detail
11.13.2 Leo Pharma Business Overview
11.13.3 Leo Pharma Onychomycosis Drugs Introduction
11.13.4 Leo Pharma Revenue in Onychomycosis Drugs Business (2019-2024)
11.13.5 Leo Pharma Recent Development
11.14 Dr. Reddy's Laboratories
11.14.1 Dr. Reddy's Laboratories Company Detail
11.14.2 Dr. Reddy's Laboratories Business Overview
11.14.3 Dr. Reddy's Laboratories Onychomycosis Drugs Introduction
11.14.4 Dr. Reddy's Laboratories Revenue in Onychomycosis Drugs Business (2019-2024)
11.14.5 Dr. Reddy's Laboratories Recent Development
11.15 Medimetriks Pharmaceuticals
11.15.1 Medimetriks Pharmaceuticals Company Detail
11.15.2 Medimetriks Pharmaceuticals Business Overview
11.15.3 Medimetriks Pharmaceuticals Onychomycosis Drugs Introduction
11.15.4 Medimetriks Pharmaceuticals Revenue in Onychomycosis Drugs Business (2019-2024)
11.15.5 Medimetriks Pharmaceuticals Recent Development
11.16 Xiuzheng Pharmaceutical
11.16.1 Xiuzheng Pharmaceutical Company Detail
11.16.2 Xiuzheng Pharmaceutical Business Overview
11.16.3 Xiuzheng Pharmaceutical Onychomycosis Drugs Introduction
11.16.4 Xiuzheng Pharmaceutical Revenue in Onychomycosis Drugs Business (2019-2024)
11.16.5 Xiuzheng Pharmaceutical Recent Development
11.17 Letai
11.17.1 Letai Company Detail
11.17.2 Letai Business Overview
11.17.3 Letai Onychomycosis Drugs Introduction
11.17.4 Letai Revenue in Onychomycosis Drugs Business (2019-2024)
11.17.5 Letai Recent Development
11.18 Qilu Pharmaceutical
11.18.1 Qilu Pharmaceutical Company Detail
11.18.2 Qilu Pharmaceutical Business Overview
11.18.3 Qilu Pharmaceutical Onychomycosis Drugs Introduction
11.18.4 Qilu Pharmaceutical Revenue in Onychomycosis Drugs Business (2019-2024)
11.18.5 Qilu Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Onychomycosis Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Medicine
Table 3. Key Players of External Medicine
Table 4. Global Onychomycosis Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Onychomycosis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Onychomycosis Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Onychomycosis Drugs Market Share by Region (2019-2024)
Table 8. Global Onychomycosis Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Onychomycosis Drugs Market Share by Region (2025-2030)
Table 10. Onychomycosis Drugs Market Trends
Table 11. Onychomycosis Drugs Market Drivers
Table 12. Onychomycosis Drugs Market Challenges
Table 13. Onychomycosis Drugs Market Restraints
Table 14. Global Onychomycosis Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Onychomycosis Drugs Market Share by Players (2019-2024)
Table 16. Global Top Onychomycosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis Drugs as of 2023)
Table 17. Ranking of Global Top Onychomycosis Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Onychomycosis Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Onychomycosis Drugs Product Solution and Service
Table 21. Date of Enter into Onychomycosis Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Onychomycosis Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Onychomycosis Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Onychomycosis Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Onychomycosis Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Onychomycosis Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Onychomycosis Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Onychomycosis Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Onychomycosis Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Onychomycosis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Onychomycosis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Onychomycosis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Onychomycosis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Onychomycosis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Onychomycosis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Onychomycosis Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Onychomycosis Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Onychomycosis Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Onychomycosis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Onychomycosis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Onychomycosis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Onychomycosis Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Onychomycosis Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Onychomycosis Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Johnson & Johnson Company Detail
Table 47. Johnson & Johnson Business Overview
Table 48. Johnson & Johnson Onychomycosis Drugs Product
Table 49. Johnson & Johnson Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 50. Johnson & Johnson Recent Development
Table 51. GSK Company Detail
Table 52. GSK Business Overview
Table 53. GSK Onychomycosis Drugs Product
Table 54. GSK Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Novartis Company Detail
Table 57. Novartis Business Overview
Table 58. Novartis Onychomycosis Drugs Product
Table 59. Novartis Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Onychomycosis Drugs Product
Table 64. Pfizer Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Bausch Health Company Detail
Table 67. Bausch Health Business Overview
Table 68. Bausch Health Onychomycosis Drugs Product
Table 69. Bausch Health Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 70. Bausch Health Recent Development
Table 71. Kaken Pharmaceutical Company Detail
Table 72. Kaken Pharmaceutical Business Overview
Table 73. Kaken Pharmaceutical Onychomycosis Drugs Product
Table 74. Kaken Pharmaceutical Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 75. Kaken Pharmaceutical Recent Development
Table 76. Galderma Company Detail
Table 77. Galderma Business Overview
Table 78. Galderma Onychomycosis Drugs Product
Table 79. Galderma Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 80. Galderma Recent Development
Table 81. Bayer Company Detail
Table 82. Bayer Business Overview
Table 83. Bayer Onychomycosis Drugs Product
Table 84. Bayer Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 85. Bayer Recent Development
Table 86. Lumenis Company Detail
Table 87. Lumenis Business Overview
Table 88. Lumenis Onychomycosis Drugs Product
Table 89. Lumenis Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 90. Lumenis Recent Development
Table 91. Moberg Pharma Company Detail
Table 92. Moberg Pharma Business Overview
Table 93. Moberg Pharma Onychomycosis Drugs Product
Table 94. Moberg Pharma Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 95. Moberg Pharma Recent Development
Table 96. Cipla Company Detail
Table 97. Cipla Business Overview
Table 98. Cipla Onychomycosis Drugs Product
Table 99. Cipla Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 100. Cipla Recent Development
Table 101. Biofrontera Company Detail
Table 102. Biofrontera Business Overview
Table 103. Biofrontera Onychomycosis Drugs Product
Table 104. Biofrontera Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 105. Biofrontera Recent Development
Table 106. Leo Pharma Company Detail
Table 107. Leo Pharma Business Overview
Table 108. Leo Pharma Onychomycosis Drugs Product
Table 109. Leo Pharma Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 110. Leo Pharma Recent Development
Table 111. Dr. Reddy's Laboratories Company Detail
Table 112. Dr. Reddy's Laboratories Business Overview
Table 113. Dr. Reddy's Laboratories Onychomycosis Drugs Product
Table 114. Dr. Reddy's Laboratories Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 115. Dr. Reddy's Laboratories Recent Development
Table 116. Medimetriks Pharmaceuticals Company Detail
Table 117. Medimetriks Pharmaceuticals Business Overview
Table 118. Medimetriks Pharmaceuticals Onychomycosis Drugs Product
Table 119. Medimetriks Pharmaceuticals Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 120. Medimetriks Pharmaceuticals Recent Development
Table 121. Xiuzheng Pharmaceutical Company Detail
Table 122. Xiuzheng Pharmaceutical Business Overview
Table 123. Xiuzheng Pharmaceutical Onychomycosis Drugs Product
Table 124. Xiuzheng Pharmaceutical Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 125. Xiuzheng Pharmaceutical Recent Development
Table 126. Letai Company Detail
Table 127. Letai Business Overview
Table 128. Letai Onychomycosis Drugs Product
Table 129. Letai Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 130. Letai Recent Development
Table 131. Qilu Pharmaceutical Company Detail
Table 132. Qilu Pharmaceutical Business Overview
Table 133. Qilu Pharmaceutical Onychomycosis Drugs Product
Table 134. Qilu Pharmaceutical Revenue in Onychomycosis Drugs Business (2019-2024) & (US$ Million)
Table 135. Qilu Pharmaceutical Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Onychomycosis Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Onychomycosis Drugs Market Share by Type: 2023 VS 2030
Figure 3. Oral Medicine Features
Figure 4. External Medicine Features
Figure 5. Global Onychomycosis Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Onychomycosis Drugs Market Share by Application: 2023 VS 2030
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Onychomycosis Drugs Report Years Considered
Figure 11. Global Onychomycosis Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Onychomycosis Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Onychomycosis Drugs Market Share by Region: 2023 VS 2030
Figure 14. Global Onychomycosis Drugs Market Share by Players in 2023
Figure 15. Global Top Onychomycosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Onychomycosis Drugs as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Onychomycosis Drugs Revenue in 2023
Figure 17. North America Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Onychomycosis Drugs Market Share by Country (2019-2030)
Figure 19. United States Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Onychomycosis Drugs Market Share by Country (2019-2030)
Figure 23. Germany Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Onychomycosis Drugs Market Share by Region (2019-2030)
Figure 31. China Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Onychomycosis Drugs Market Share by Country (2019-2030)
Figure 39. Mexico Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Onychomycosis Drugs Market Share by Country (2019-2030)
Figure 43. Turkey Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Onychomycosis Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Johnson & Johnson Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 46. GSK Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 47. Novartis Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 49. Bausch Health Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 50. Kaken Pharmaceutical Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 51. Galderma Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 52. Bayer Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 53. Lumenis Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 54. Moberg Pharma Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 55. Cipla Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 56. Biofrontera Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 57. Leo Pharma Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 59. Medimetriks Pharmaceuticals Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 60. Xiuzheng Pharmaceutical Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 61. Letai Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 62. Qilu Pharmaceutical Revenue Growth Rate in Onychomycosis Drugs Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
